Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
TransOre is a U.A.E. registered entity managing a portfolio of global commodity supply chains. TransOre facilitates the marketing, processing, financing and transportation of essential raw materials. TransOre aims to source bulk commodities from low cost regions in Sub-Saharan Africa and supply high demand markets in Europe, the Middle East, Asia and beyond.
Key to TransOre’s success is an integrated portfolio of strategic assets, which ensure supply chain reliability.
This is my prediction here
So im in at 5p, i will add up on placing as much as i can, then let it go to 50p (£15 Million mcap) or even £1 (£30 Million mcap)
Fundamental is good.
COVID-19 situation is behind the next year decline in revenue.
Once it cleared and audit around Serba settled, we will see this back to 5p level.
Im here for couple of years at 40% loss but don’t mind it just paper loss.
Cizzle Biotechnology is in the early stages of developing a blood test for the early detection of a majority of the different forms of lung cancer.
So they are in early stage. So from my experience it needs around 1-2 years to develop the test and get CE or/and FDA clearance.
What do you think guys is it good to invest now or wait more as i can see the £2.2m is not enough for 1/2 years so they need more funds before any major news.
That big stake to take. Could be some news soon
Hey Bwana.
I have just emailed BION and i hope i get a reply or RNS
Dear All,
I have invested in Bion Plc 3 months ago. I have also increased my holdings on trading update RNS to around 300K shares.
Recently, with the audit issues around Serba Dinamik and its share price falling down along with its related companies (Bion included) we request RNS of clarification of the impact on BION for the short and mid term.
Please note that I know they are separate entity and listed of different market, but the uncertainty of the audit issue may affect future funds and my lead to Decline in SP.
RNS clarification would be amazing to give the market re-assurance on Bion future.
Thank you for your understanding and looking forward for your reply or RNS.